Global Osteoporosis Drugs Market Size To Worth USD 20.78 Billion by 2033 | CAGR of 3.47%
Category: HealthcareGlobal Osteoporosis Drugs Market Size worth To USD 20.78 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Osteoporosis Drugs Market Size is Expected to Grow from USD 14.78 Billion in 2023 to USD 20.78 Billion by 2033, at a CAGR of 3.47% during the forecast period 2023-2033. 
Get more details on this report -
Browse key industry insights spread across 280 pages with 100 Market data tables and figures & charts from the report on the "Global Osteoporosis Drugs Market Size, Share, and COVID-19 Impact Analysis, By Type (Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM), Rank Ligand Inhibitors, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/osteoporosis-drugs-market
The osteoporosis drugs market is the worldwide industry focused on developing, producing, and distributing medications used to treat and prevent osteoporosis, a condition characterised by deteriorating bones and an increased risk of fractures. These drugs are intended to delay bone loss, increase bone density, and reduce fracture risk. They are mostly recommended for age-related bone loss, postmenopausal osteoporosis, and osteoporosis caused by glucocorticoids. The market for osteoporosis drugs aims to improve the quality of life for those affected by the illness by providing drugs that help manage and prevent it. Increased healthcare spending on drug development and discovery, together with growing awareness of available medicines, further promotes market expansion. A growing focus on preventive healthcare, an aging population, an increase in fractures, rising osteoporosis incidence, and ongoing advancements in medical technology are some of the trends propelling the market's explosive growth. The advancements assist market expansion by improving patient outcomes, expanding treatment options, and boosting the effectiveness of osteoporosis drugs. However, the main factors restricting osteoporosis drugs market expansion include high treatment costs, adverse effects, regulatory obstacles, low patient compliance, and patent expirations.
The bisphosphonates segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the type, the osteoporosis drugs market is classified into bisphosphonates, parathyroid hormone therapy, calcitonin, selective estrogen inhibitors modulator (SERM), rank ligand inhibitors, and others. Among these, the bisphosphonates segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe. Bisphosphonates are used to effectively lower the risk of fracture and bone loss owing to their capacity to prevent bone resorption and increase bone density.
The retail pharmacies segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the distribution channel, the osteoporosis drugs market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the retail pharmacies segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe. Retail pharmacies are essential for making drugs easily accessible, especially for elderly people with long-term medical issues.
North America is estimated to hold the largest share of the osteoporosis drugs market over the forecast period.
Get more details on this report -
North America is estimated to hold the largest share of the osteoporosis drugs market over the forecast period. Numerous significant pharmaceutical companies, extensive research initiatives, and a high degree of knowledge regarding osteoporosis treatment are driving the market for osteoporosis drugs in North America.
Asia Pacific is predicted to grow at the fastest CAGR growth in the osteoporosis drugs market over the forecast period. Asia Pacific is becoming a major market for osteoporosis medications due to government programs supporting accessible treatment choices and partnerships between pharmaceutical firms and healthcare professionals.
Major key players in the osteoporosis drugs market include Merck & Co., Inc., Radius Health, Inc., Pfizer Inc., UCB S.A., Novartis AG, GSK plc, Amgen Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In November 2023, in the US, Teva Pharmaceuticals' generic version of Forteo (teriparatide injectable) was approved by the FDA. Teva's market share in osteoporosis medications increased with its approval, which gave postmenopausal women and men with primary or hypogonadal osteoporosis, as well as those with glucocorticoid-induced fractures that are at high risk of fractures, a therapeutic alternative.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the osteoporosis drugs market based on the below-mentioned segments:
Global Osteoporosis Drugs Market, By Type
- Bisphosphonates
- Parathyroid Hormone Therapy
- Calcitonin
- Selective Estrogen Inhibitors Modulator (SERM)
- Rank Ligand Inhibitors
- Others
Global Osteoporosis Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Osteoporosis Drugs Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?